Evaluation of sorivudine (BV-araU) versus acyclovir in the treatment of acute localized herpes zoster in human immunodeficiency virus-infected adults. The Multinational Sorivudine Study Group.

Bodsworth, N J; Boag, F; Burdge, D; Généreux, M; Borleffs, J C; Evans, B A; Modai, J; Colebunders, R; Thomas, M; DeHertogh, D; Pacelli, L; Thomis, J

Bodsworth, N J; Boag, F; Burdge, D; Généreux, M; Borleffs, J C; Evans, B A; Modai, J; Colebunders, R; Thomas, M; DeHertogh, D; Pacelli, L; Thomis, J.

Affiliation

Bodsworth NJ; Sydney Hospital and Taylor Square Private Clinic, Australia.

J Infect Dis ; 176(1): 103-11, 1997 Jul.

Article in En | MEDLINE | ID: mdl-9207355

Subject(s)

Acyclovir/therapeutic use; Antiviral Agents/therapeutic use; Arabinofuranosyluracil/analogs & derivatives; HIV Infections/complications; Herpes Zoster/drug therapy; Acute Disease; Acyclovir/adverse effects; Adolescent; Adult; Arabinofuranosyluracil/adverse effects; Arabinofuranosyluracil/therapeutic use; Double-Blind Method; Humans; Middle Aged; Patient Compliance

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Arabinofuranosyluracil / Acyclovir / HIV Infections / Herpes Zoster Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Middle aged Language: En Journal: J Infect Dis Year: 1997 Document type: Article Affiliation country: Australia Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links